NARI Inari Medical, Inc.

Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

$92.76  +2.75 (3.06%)
As of 06/18/2021 15:59:53 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  05/22/2020
Outstanding shares:  49,675,586
Average volume:  556,653
Market cap:   $4,471,299,496
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    45332Y109
ISIN:        US45332Y1091
Sedol:      BLDRF10
Valuation   (See tab for details)
PE ratio:   268.51
PB ratio:   21.55
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy